Sumary of BioNTech-Pfizer confident about their vaccine for kids:
- And indeed, back in May, the German half of the BioNTech-Pfizer COVID-19 vaccine team announced it was aiming to submit applications for emergency use authorizations in the US and the European Union for children aged 2 to 5 years and those aged 5-11 years by September.
- But fortunately for BioNTech-Pfizer — the joint-effort vaccine now known as Comirnaty or just Pfizer — their side of the plans appear to be on track.
- In an interview published by German weekly Der Spiegel on Friday, BioNTech’s co-founder and chief medical officer, Özlem Türeci, is reported as saying that the firm is already preparing production of the vaccine for children — ahead of approval.
- Türeci told the magazine, “It’s the same vaccine but a lower dose.
- ” Children and COVID vaccines It’s generally thought that COVID vaccines produce the same side effects in children as they do in adults.
- ” COVID vaccines are considered “reactogenic” — they are expected to produce strong physical reactions.
- Early trials ‘inadequate’ Drug regulators have pressed for special clinical trials of COVID vaccines in children.
- In the US, for instance, the FDA demanded BioNTech-Pfizer and their competitor, Moderna, which produces Spikevax, conduct broader trials — that was also back in May.